UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000007820
Receipt No. R000001265
Official scientific title of the study A Randamized, Prospective and Comparative Study of Topical Timolol and Latanoprost in Uveitic Glaucoma
Date of disclosure of the study information 2012/04/23
Last modified on 2018/04/28 (Ver. 7)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study A Randamized, Prospective and Comparative Study of Topical Timolol and Latanoprost in Uveitic Glaucoma
Title of the study (Brief title) A Comparative Study of Topical Timolol and Latanoprost in Uveitic Glaucoma
Region
Japan

Condition
Condition Uveitic Glaucoma
Classification by specialty
Ophthalmology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 We evaluated effects on the intraocular pressure (IOP) lowering and safety of topical timolol and latanoprost in UG prospectively.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes intraocular pressure-lowering ratio
Key secondary outcomes 1)flare value in the anterior chamber
2)side effects(conjunctival injection, corneal erosion)
3)macular thickness measured by OCT

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Open -no one is blinded
Control Active
Stratification NO
Dynamic allocation YES
Institution consideration Institution is considered as a block.
Blocking YES
Concealment Numbered container method

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 Latanoprost eye drop
Interventions/Control_2 Timolol-XE eye drop
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria 1)The patients received topical corticosteroid for uveitis.
2) There was no strong inflammation in the anterior chamber within these 3 months.
3) The objective eyes didn't received anti-glaucoma eye drops.
4) 30mmHg> Baseline IOP (before starting treatment) >=21mmHg
Key exclusion criteria 1) herpetic iritis
2) PAS index>25% (secondary angle closure glaucoma)
3) The patients who received Argon Laser Trabeculoplasty within 3 months.
4) The patients who received intraocular surgeries within 6 months.
5)The patients who had asthma or arrythmia, and couldn't receive timolol.
Target sample size 120

Research contact person
Name of lead principal investigator Toshikatsu Kaburaki
Organization University of Tokyo Hospital
Division name Ophthalmology
Address 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan
TEL 03-3815-5411
Email kabutosi-tky@umin.ac.jp

Public contact
Name of contact person Toshikatsu Kaburaki
Organization University of Tokyo Hospital
Division name Ophthalmology
Address 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan
TEL 03-3815-5411
Homepage URL
Email kabutosi-tky@umin.ac.jp

Sponsor
Institute Deportment of Ophthalmology, University of Tokyo Hospital
Institute
Department

Funding Source
Organization Deportment of Ophthalmology, University of Tokyo Hospital
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization Japan

Other related organizations
Co-sponsor Department of Ophthalmology, Teikyo University Hospital
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 東京大学附属病院眼科(東京都)

Other administrative information
Date of disclosure of the study information
2012 Year 04 Month 23 Day

Progress
Recruitment status Completed
Date of protocol fixation
2007 Year 02 Month 01 Day
Anticipated trial start date
2008 Year 02 Month 01 Day
Last follow-up date
2015 Year 12 Month 01 Day
Date of closure to data entry
2016 Year 03 Month 01 Day
Date trial data considered complete
2016 Year 06 Month 01 Day
Date analysis concluded
2017 Year 12 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2012 Year 04 Month 23 Day
Last modified on
2018 Year 04 Month 28 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000001265